“Accelerating Clinical Trials in the EU for better clinical trials that address patients’ needs”, a joint initiative of the EU Commission, the European Medicines Agency Heads of Medicines Agencies (HMA)

Archive, News / By /
On January 2022 a new initiative launched by the European Commission, the Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) aims to transform how clinical trials are initiated, designed, and run. This initiative, called “Accelerating Clinical Trials in the EU for better clinical trials that address patients’ needs“, aims to further develop the EU as a focal point for clinical research, promote the development of high quality, safe and effective medicines, and to better integrate clinical research in the European health system.

Read more about this initiative on the EMA wesbite at this link

Related Posts

TRANSLATE »
Scroll to Top